This compound is a pharmaceutical intermediate specifically used in the manufacturing of orlistat. It features a lactone ring with alcohol and ester functional groups, indicating a role in the synthesis of this anti-obesity medication.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 104801-96-9
2-Amino-3-iodopyridine
Pharmaceutical intermediate for synthesis
(2S)-2-[[2-(9H-fluoren-9-ylmethoxycarbonylamino)acetyl]amino]-5-[[2-[(2,2,4,6,7-pentamethyl-3H-1-benzofuran-5-yl)sulfonyl]hydrazinyl]methylideneamino]pentanoic acid
Fmoc-protected amino acid building block
Ethyl 4-chloro-3-hydroxybutanoate
pharmaceutical intermediate
2,2-dimethyl-2,3-dihydro-1H-inden-1-one
pharmaceutical intermediate
2,3,4,6-tetrakis-o-trimethylsilyl-d-gluconolactone
Pharmaceutical intermediate for empagliflozin
3,4,5-trihydroxy-6-oxooxane-2-carbaldehyde
active pharmaceutical ingredient
DL-MEVALONOLACTONE-4,4,5,5,6,6,6-D7
isotopically labeled mevalonolactone standard
DL-MEVALONOLACTONE-4,4,5,5-D4
isotopically labeled research standard
(3S,4S,6R)-3-hexyl-4-hydroxy-6-undecyloxan-2-one
LRXRIVSWHMVULO-HKBOAZHASA-N
CCCCCCCCCCC[C@@H]1C[C@@H]([C@@H](C(=O)O1)CCCCCC)O